健康系统干预改善慢阻肺出院后照护的阶梯楔形临床试验
该阶梯楔形临床试验在退伍军人医疗系统纳入365名基层医生及其慢阻肺急性加重出院患者,由多学科团队通过电子会诊提供主动专科支持建议。干预改善了临床慢阻肺问卷评分(-0.47;95%CI -0.85至-0.09),但未降低180天再入院和/或死亡率(调整OR 0.83;95%CI 0.49至1.38)。
要点
- 主动多学科电子会诊可改善慢阻肺出院患者生活质量
- 该干预未显著降低180天再入院和/或死亡风险
- 77.3%的专科建议被基层医生采纳
核心结论
- 务实的健康系统层面主动专科支持干预改善了慢阻肺出院患者的生活质量,但未减少180天再入院或死亡。
研究设计与样本
- 阶梯楔形临床试验,纳入两个退伍军人事务部医疗中心和10个门诊诊所的365名基层医生及其慢阻肺出院患者。
- 30个月内352名患者符合标准,对照期191名(54.3%),干预期161名(45.7%)。
主要发现
- 干预组临床慢阻肺问卷评分改善具有临床意义(-0.47;95%CI -0.85至-0.09;52.6%缺失)。
- 180天再入院和/或死亡的调整OR为0.83(95%CI 0.49至1.38),未达统计学显著。
- 干预组161名患者共录入519条建议为未签名医嘱,其中401条(77.3%)被采纳。
临床怎么用
- 多学科团队主动审阅病历并通过电子会诊向基层医生提供建议,可作为改善慢阻肺出院后生活质量的策略。
- 将建议以未签名医嘱形式录入供基层医生接受、修改或取消,有助于提高专科建议的落地率。
局限性
- 临床慢阻肺问卷评分缺失比例达52.6%。
- 180天再入院和/或死亡结局的95%CI较宽,研究可能不足以检出差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Patients discharged from the hospital for chronic obstructive pulmonary disease (COPD) exacerbation have impaired quality of life and frequent readmission and death. Clinical trials to reduce readmission demonstrate inconsistent results, including some demonstrating potential harms. Objectives: We tested whether a pragmatic proactive interdisciplinary and virtual review of patients discharged after hospitalization for COPD exacerbation would improve quality of life, using the Clinical COPD Questionnaire, and reduce all-cause 180-day readmission and/or mortality. Methods: We performed a stepped-wedge clinical trial. We enrolled primary care providers and their patients after hospital discharge for COPD at two Department of Veterans Affairs medical centers and 10 outpatient clinics. A multidisciplinary team reviewed health records and developed treatment recommendations delivered to primary care providers via E-consult. We facilitated uptake by entering recommendations as unsigned orders that could be accepted, modified, or canceled. Providers and patients made all final treatment decisions. Measurements and Main Results: We enrolled 365 primary care providers. Over a 30-month period, 352 patients met eligibility criteria, with 191 (54.3%) patients participating in the control and 161 (45.7%) in the intervention. The intervention led to clinically significant better Clinical COPD Questionnaire scores (-0.47; 95% confidence interval [CI], -0.85 to -0.09; 52.6% missing) but did not reduce 180-day readmission and/or mortality (adjusted odds ratio, 0.83; 95% CI, 0.49 to 1.38), in part because of wide CIs. Among the 161 patients in the intervention group, we entered 519 recommendations as unsigned orders, of which 401 (77.3%) were endorsed. Conclusions: A pragmatic health system-level intervention that delivered proactive specialty supported care improved quality of life but did not reduce 180-day readmission or death. Clinical trial registered with www.clinicaltrials.gov (NCT02021955).
引用
- Au DH, Collins MP, Berger DB, et al. Health System Approach to Improve Chronic Obstructive Pulmonary Disease Care after Hospital Discharge: Stepped-Wedge Clinical Trial. Am J Respir Crit Care Med. 2022. PMID: 35333140. doi:10.1164/rccm.202107-1707OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。